INTERVENTIONAL MANAGEMENT OF PATIENTS WITH CHRONIC CORONARY HEART DISEASE
##article.subject##:
teri orqali koronar aralashuv, stentlash, o'tkir koronar sindrom, infarktdan keyingi kardioskleroz, statinlar##article.abstract##
Keksa bemorlarning o'limining etakchi sababi hozirgi vaqtda koronar yurak kasalligidir. Yaqinda mamlakatimizning deyarli barcha viloyatlarida revaskulyarizatsiya davolash markazlari ochilmoqda. Xususan, teri orqali koronar aralashuvlar hayot sifatini yaxshilash uchun bo'yicha samarali ishlar olib borilmoqda. Ushbu endovaskulyar tashabbuslar hozirgi kunda bemorlarning ahvolini sezilarli darajada yaxshilash va jismoniy mashqlar bardoshliligini oshirish, odamlarni normal kundalik hayotga qaytarish uchun yuqori samarali davolash usuli hisoblanadi. Tadqiqotimizning maqsadi surunkali koronar yurak kasalligi bo'lgan bemorlarni davolash usullaridan biri sifatida teri orqali koronar aralashuv imkoniyatlarini baholash edi. Ushbu maqolada turli xil stentlash bilan teri orqali koronar aralashuv o'tkazilgan keksa va keksa bemorlarning retrospektiv tahlili o'tkazildi. Tahlil davomida tahlillar shuni ko'rsatdiki, bemorlarning aksariyati keksa yoshda va Oks tashxisi qo'yilgan. 163 bemorda 337 dan ortiq endovaskulyar aralashuv amalga oshirildi. Oks bilan og'rigan bemorlarda koronar tomirlarning stentlanishi miyokard infarkti va yuqori darajada komorbidlik darajasi yuqori bo'lgan keksa va keksa odamlarda yuzaga keladigan barcha jiddiy asoratlarni oldini olish uchun zarurdir.
Библиографические ссылки
Alyavi, B., & Uzokov, J. (2018). TCTAP C-156 Successful Percutaneous Coronary Intervention of a Left Circumflex Artery Departing from the Right Coronary Sinus. Journal of the American College of Cardiology, 71(16 Supplement), S225-S226.
Bainey KR, Selzer F, Cohen HA, et al. Comparison of Three Age Groups Regarding Safety and Efficacy of Drug-Eluting Stents (from the National Heart, Lung, and Blood Institute Dynamic Registry). The American journal of cardiology. 2012; 109(2): 195-201.
Belyalov F.I. THE SPECIFICS OF ISCHEMIC HEART DISEASE MANAGEMENT IN ELDERLY. Russian Journal of Cardiology. 2017;(3):72-76. (In Russ.) https://doi.org/10.15829/1560-4071-2017-3-72-76
Boden WE, O’Rourke RA, Teo KK, et al. Optimal Medical Therapy with or without PCI for Stable Coronary Disease. N. Eng.lJ. Med., 2007; 356: 1503-16.].
Boekholdt S, Hovingh G, Mora S, et al. Very Low Levels of Atherogenic Lipoproteins and the Risk for Cardiovascular Events: A Meta-Analysis of Statin Trials. J. Am. Coll. Cardiol. 2014; 64(5): 485-94.
Cantor WJ, Mehta SR, Yuan F, et al. Radial versus femoral access for elderly patients with acute coronary syndrome undergoing coronary angiography and intervention: insights from the RIVAL trial. American Heart Journal. 2015; 170(5): 880-6.
European Society of Cardiology. 2021 ESC guidelines on the management of stable coronary artery disease. Eur. Heart. J. 2013; 34: 2949-3003.
Genders TSS, Steyerberg EW, Alkadhi H, et al. A clinical prediction rule for the diagnosis of coronary artery disease: validation, updating, and extension. Eur. Heart. J. 2011; 32(11): 1316-30.
Hannan EL, Zhong Y, Berger PB, et al. Comparison of Intermediate-Term Outcomes of Coronary Artery Bypass Grafting Versus Drug-Eluting Stents for Patients ≥75 Years of Age. The American journal of cardiology. 2014; 113(5): 803-8.
Irina Agababyan, Sitora Soliyeva, Yulduz Ismoilova.Condition of Coronary Arteries and Change of Lipid Profile in Coronary Heart Disease. Annals of R.S.C.B., ISSN:1583-6258, Vol. 25, Issue 1, 2021, Pages. 207 – 213. ORCID iDhttps://orcid.org/0000-0003-2650-4445St.
Mangiacapra F, Ricottini E, Di Gioia G, et al. Comparison Among Patients ≥75 Years Having Percutaneous Coronary Angioplasty Using Drug-Eluting Stents Versus Bare Metal Stents. American Journal of Cardiology. 2015; 115: 1179-84.
Veledar E, Fazel R, Shaw L, et al. Analyzing recent trends in coronary heart disease (CHD) deaths among the elderly in the United States using data from official statistical sources. Med. Arch. 2010; 64(5): 281-3.
Zhang Z, Kolm P, Grau-Sepulveda MV, et al. Cost-Effectiveness of Revascularization Strategies: The ASCERT Study. J. Am. Coll. Cardiol. 2015; 65(1): 1-11.
Агабабян И.Р., Солеева С.Ш. Место статинов в комплексном лечении SARS-COV-2. Вопросы науки и образования №14 (139) 2021. с.70-80.
Всемирная организация здравоохранения. Семьдесят третья сессия всемирной ассамблеи здравоохранения а73/inf./2 пункт 15.1повестки дня 5 мая 2020 г.
Мурадов М.М. диссер. Тактика хирургического лечения ишемической болезни сердца у пациентов старше 70 лет 2016 г. с.13.
